These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16673297)

  • 1. Current issues and future directions in treatment.
    Hui CK; Lau GK
    Semin Liver Dis; 2006 May; 26(2):192-7. PubMed ID: 16673297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Feld JJ; Heathcote EJ
    Semin Liver Dis; 2006 May; 26(2):116-29. PubMed ID: 16673290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.
    Hadziyannis SJ; Papatheodoridis GV
    Semin Liver Dis; 2006 May; 26(2):130-41. PubMed ID: 16673291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW; Chen YG
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B.
    Kim BK; Han KH; Ahn SH
    Digestion; 2011; 84 Suppl 1():29-34. PubMed ID: 22156483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customizing the management of chronic hepatitis B virus infection.
    Gish RG; Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():9-17. PubMed ID: 17701845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis B--who should be treated?
    Coffin CS; Lee SS
    MedGenMed; 2006 Mar; 8(1):75. PubMed ID: 16915205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis B: antiviral treatment guidelines].
    Hézode C; Pawlotsky JM
    Rev Prat; 2010 Jun; 60(6):751-8. PubMed ID: 20623887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of chronic hepatitis B: 2009 update.
    Morgan M; Keeffe EB
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):5-22. PubMed ID: 19212304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing management strategies in special patient populations.
    Sherman M
    Am J Gastroenterol; 2006; 101 Suppl 1():S26-31. PubMed ID: 16448449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.